NCT06958445View on ClinicalTrials.gov

Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Breast Carcinoma
Interventions
DRUG

Alginos Oral Suspension

containing: Sodium alginate 50mg/mL Sodium bicarbonate 26.7mg/mL Calcium carbonate 16mg/mL

Trial Locations (1)

10629

Taipei City Hospital, Renai Branch, Taipei

All Listed Sponsors
lead

Taipei City Hospital

OTHER_GOV